
The Pawtucket City Council accepts email testimony for Public Input Period/Public Hearings at cityclerk@pawtucketri.com until 4:00 p.m. on the day of the meeting.
Please type COUNCIL INPUT in the Subject box.
The public may also participate at Public Input Period/Public Hearings via videoconference:
Must join 10 minutes prior to meeting.
DIAL: 1-888-475-4499 MEETING ID: 898 0417 7941
OR Join Online at www.Zoom.us - Click Join a Meeting – PASSWORD: CC25
OR https://us06web.zoom.us/j/89804177941
AGENDA
TO: All Members of the Pawtucket City Council
Frank J. Milos, Jr., Esq., City Solicitor
FROM: Richard J. Goldstein, MMC, City Clerk
DATE: September 4, 2025
SUBJECT: COMMITTEE OF THE WHOLE
You are requested to attend a meeting of the City Council Committee of the Whole, to be held on Wednesday, September 10, 2025, at 6:20 p.m., at the Pawtucket Municipal Annex, 100 Freight Street, Second Floor – Room 204, Parking Lot Entrance at 75 Sabin Street, Pawtucket, Rhode Island.
The purpose of this meeting is for discussion and/or consideration of the following:
A portion of this meeting may be held in Executive Session pursuant to § 42-46-4 and § 42-46-5 (A)(2) of the General Laws of the State of Rhode Island regarding pending litigation.
City of Pawtucket, Rhode Island vs. Amerisourcebergen Drug Corporation, et al. (Case 1:18-cv-00139-WES-LDA) (Purdue Pharma/Sackler; Alvogen Inc.; Amneal Pharmaceuticals, Inc.; Apotex Inc.; Hikma Pharmaceuticals USA, Inc.; Indivior Inc.; Mylan Pharmaceuticals Inc.; Sun Pharmacuetical Industries, Inc.; and Zydus Pharmaceuticals, Inc.)
This meeting is being called by Council President Terrence E. Mercer.